The Claim

Elevated circulating levels of trimethylamine N-oxide (TMAO) are associated with a 7.6% increased risk of all-cause mortality per 10 μmol/L increase and are linked to greater atherosclerotic burden, plaque instability, and adverse cardiovascular outcomes in humans.

Source: Gut microbiota dysbiosis–induced chronic inflammation as a driver of atherosclerosis: cellular crosstalk and host–microbe interactions

What the research says

Roughly balanced

Support and challenge are close. The picture may shift as more studies come in.

Supports
2score
Challenges
0score

These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.

Correlation
1 study reviewed
In plain English

Higher levels of trimethylamine N-oxide in the blood are associated with a 7.6% higher risk of death from any cause for every 10 μmol/L increase, and are also linked to more severe artery plaque, unstable plaques, and worse heart-related events in humans.

See the scientific wording

Elevated circulating levels of trimethylamine N-oxide (TMAO) are associated with a 7.6% increased risk of all-cause mortality per 10 μmol/L increase and are linked to greater atherosclerotic burden, plaque instability, and adverse cardiovascular outcomes in humans, suggesting TMAO serves as a biomarker of gut microbiota-driven metabolic dysfunction that correlates with cardiovascular risk.

Why this might work

Imbalanced gut bacteria break down food components into a compound called TMA, which the liver turns into TMAO. TMAO makes immune cells in the artery walls take in more bad cholesterol and stop removing it, forming fatty plaques. At the same time, the gut lining becomes leaky, letting bacterial toxins into the blood. These toxins trigger persistent inflammation in blood vessels, activate immune cells, and cause plaques to become unstable. The inflammation also reprograms bone marrow cells to overreact to future threats, making the damage worse over time.

Verified mechanismbased on 1 study

What the research says

1 study

  1. Study: Gut microbiota dysbiosis–induced chronic inflammation as a driver of atherosclerosis: cellular crosstalk and host–microbe interactions

    This study says that when gut bacteria are out of balance, they make chemicals like TMAO that are linked to clogged arteries and heart problems — so higher TMAO levels are a warning sign, even if they don’t directly cause the damage.

Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies

Fit Body Science verdict — we translate health claims into clear verdicts backed by peer-reviewed research.

Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.